Literature DB >> 22851204

Activity of the leukotriene pathway in Barrett's metaplasia and oesophageal adenocarcinoma.

James David Shutt1, Philip Boger, James Richard Neale, Praful Patel, Anthony Peter Sampson.   

Abstract

OBJECTIVE: Leukotriene (LT) B(4) is a lipid inflammatory mediator implicated in tumorigenesis in animal models of Barrett's oesophagitis, but little is known about the cysteinyl-leukotrienes (LTC(4), LTD(4), LTE(4)), which have distinct inflammatory and tumorigenic actions in other tissues. We recently showed that the terminal enzymes for the synthesis of both LT families are highly expressed in human oesophageal adenocarcinoma (OA) tissues. This study therefore examined the capacity of Barrett's metaplasia (BM) and OA tissues to synthesise LTs in vitro. SUBJECTS AND METHODS: Oesophageal biopsies from patients with BM (n = 14), high-grade dysplasia (n = 2), OA (n = 11), and squamous control tissues (n = 11) were cultured with calcium ionophore A32187 (2 μM) for 60 min. LTB(4) and cysteinyl-leukotrienes were extracted and measured by specific enzyme immunoassays.
RESULTS: Levels of LTB(4) and cysteinyl-leukotrienes were 8.6-fold (P < 0.01) and 2.4-fold (P < 0.02) higher, respectively, in OA tissues than in squamous control tissues, but levels in BM tissues (n = 14) were not altered. Production of the two LT families correlated across all tissue types (r = 0.62, p < 0.00005).
CONCLUSIONS: Increased synthesis of LTB(4) and cysteinyl-leukotrienes has not previously been shown in human OA tissue and our results may indicate a role of these lipids in Barrett's disease progression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22851204     DOI: 10.1007/s00011-012-0539-2

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  42 in total

Review 1.  Leukotrienes.

Authors:  Marc Peters-Golden; William R Henderson
Journal:  N Engl J Med       Date:  2007-11-01       Impact factor: 91.245

2.  Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants.

Authors:  R C Fitzgerald; B A Onwuegbusi; M Bajaj-Elliott; I T Saeed; W R Burnham; M J G Farthing
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

Review 3.  Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention.

Authors:  X Chen; C S Yang
Journal:  Carcinogenesis       Date:  2001-08       Impact factor: 4.944

4.  The leukotriene B4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans.

Authors:  Sabina A Islam; Seddon Y Thomas; Christoph Hess; Benjamin D Medoff; Terry K Means; Christian Brander; Craig M Lilly; Andrew M Tager; Andrew D Luster
Journal:  Blood       Date:  2005-09-22       Impact factor: 22.113

5.  Increased expression of the 5-lipoxygenase pathway and its cellular localization in Barrett's adenocarcinoma.

Authors:  Philip C Boger; James D Shutt; James R Neale; Susan J Wilson; Adrian C Bateman; John W Holloway; Praful Patel; Anthony P Sampson
Journal:  Histopathology       Date:  2012-06-13       Impact factor: 5.087

6.  EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary.

Authors:  Milena Sant; Claudia Allemani; Mariano Santaquilani; Arnold Knijn; Francesca Marchesi; Riccardo Capocaccia
Journal:  Eur J Cancer       Date:  2009-01-24       Impact factor: 9.162

7.  Eicosanoid synthesis in duodenal ulcer disease: decrease in leukotriene C4 by colloidal bismuth subcitrate.

Authors:  A Ahmed; P R Salmon; C R Cairns; M Hobsley; J R Hoult
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

8.  Leukotriene A4 hydrolase in rat and human esophageal adenocarcinomas and inhibitory effects of bestatin.

Authors:  Xiaoxin Chen; Ning Li; Su Wang; Nan Wu; Jungil Hong; Xiaolong Jiao; Mark J Krasna; David G Beer; Chung S Yang
Journal:  J Natl Cancer Inst       Date:  2003-07-16       Impact factor: 13.506

Review 9.  Chemoprevention of oesophageal cancer and the AspECT trial.

Authors:  Debasish Das; Andrew P Chilton; Janusz A Jankowski
Journal:  Recent Results Cancer Res       Date:  2009

10.  Leukotrienes C4 and D4 promote angiogenesis via a receptor-mediated interaction.

Authors:  N E Tsopanoglou; E Pipili-Synetos; M E Maragoudakis
Journal:  Eur J Pharmacol       Date:  1994-06-02       Impact factor: 4.432

View more
  2 in total

Review 1.  Cross-Talk between Cancer Cells and the Tumour Microenvironment: The Role of the 5-Lipoxygenase Pathway.

Authors:  Gillian Y Moore; Graham P Pidgeon
Journal:  Int J Mol Sci       Date:  2017-01-24       Impact factor: 5.923

Review 2.  Cysteinyl Leukotriene Pathway and Cancer.

Authors:  Ming-Ju Tsai; Wei-An Chang; Cheng-Hao Chuang; Kuan-Li Wu; Chih-Hung Cheng; Chau-Chyun Sheu; Ya-Ling Hsu; Jen-Yu Hung
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.